Expression of MiR-634 in Gastric Carcinoma and Its Effects on Proliferation, Migration, and Invasion of Gastric Cancer Cells

Overview

Journal Cancer Med

Specialty Oncology

Date 2018 Feb 22

PMID 29464926

Citations 12

Authors

Jiao Guo

Chun-Dong Zhang

Jia-Xiang An

Yun-Yun Xiao

Shuai Shao

Nuo-Ming Zhou

Dong-Qiu Dai

Affiliations

Soon will be listed here.

Abstract

This study aims to observe the expression of microRNA (miR)-634 in different gastric cancer cell lines and tissues, and to study the effects of miR-634 on the proliferation, migration, and invasion of the gastric cancer cells. The miR-634 mimics and miR-634 inhibitors were transfected by lentivirus into human gastric cancer SGC-7901 and MGC-803 cells, and the miR-634 cells without transfection were used as the control group (NC group). The expression of miR-634 in the transfected cells was detected by qRT-PCR. Cell viability was measured by the CCK8 assay. The migration and invasion ability of the cells were detected by scratch assays and Transwell chamber assays, respectively, and the luciferase assay verified the binding of miR-634 to the target gene JAG1. The expression level of miR-634 in gastric cancer tissues and cell lines was significantly lower than that in normal adjacent tissues and control cells. The survival of cells was significantly decreased, and number of cells migrating and invading was decreased in the miR-634 mimics group. However, in the miR-634 inhibitor group, the opposite results were observed. Over-expression of miR-634 inhibited the proliferation, migration, and invasion of gastric cancer cell lines, and the miR-634 target gene was JAG1.

Citing Articles

Research progress on non-protein-targeted drugs for cancer therapy.

Zhang Y, Lu L, Song F, Zou X, Liu Y, Zheng X J Exp Clin Cancer Res. 2023; 42(1):62.

PMID: 36918935 PMC: 10011800. DOI: 10.1186/s13046-023-02635-y.

Hsa_circ_0081069 facilitates tongue squamous cell carcinoma progression by modulating MAP2K4 expression via miR-634.

Pan C, Su Z, Xie H, Ning Y, Li S, Xiao H Odontology. 2022; 111(2):474-486.

PMID: 36181561 DOI: 10.1007/s10266-022-00746-0.

Identification of circRNA Biomarker for Gastric Cancer through Integrated Analysis.

Hossain M, Li S, Reza M, Feng S, Zhang X, Jin Z Front Mol Biosci. 2022; 9:857320.

PMID: 35359600 PMC: 8960148. DOI: 10.3389/fmolb.2022.857320.

Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer.

Liu X, Yin Z, Wu Y, Zhan Q, Huang H, Fan J Bioengineered. 2022; 13(2):3739-3750.

PMID: 35081867 PMC: 8974081. DOI: 10.1080/21655979.2022.2029109.

Bioinformatic Analysis Identified Potentially Prognostic Long Noncoding RNAs and MicroRNAs for Gastric Cancer.

Guo J, Liu Y, Zhao P Biomed Res Int. 2021; 2021:6683136.

PMID: 34926687 PMC: 8683174. DOI: 10.1155/2021/6683136.

References

van Jaarsveld M, van Kuijk P, Boersma A, Helleman J, van IJcken W, Mathijssen R . miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015; 14:196. PMC: 4650519. DOI: 10.1186/s12943-015-0464-4. View

Liu H, Wang Y, Xing A, Shi D, Zhang H, Guo X . Prognostic Value of microRNA Signature in Patients with Gastric Cancers. Sci Rep. 2017; 7:42806. PMC: 5311868. DOI: 10.1038/srep42806. View

Oda T, Elkahloun A, Meltzer P, Chandrasekharappa S . Identification and cloning of the human homolog (JAG1) of the rat Jagged1 gene from the Alagille syndrome critical region at 20p12. Genomics. 1997; 43(3):376-9. DOI: 10.1006/geno.1997.4820. View

Li J, Zhou C, Li J, Su Z, Sang H, Jia E . Global correlation analysis for microRNA and gene expression profiles in human obesity. Pathol Res Pract. 2015; 211(5):361-8. DOI: 10.1016/j.prp.2014.11.014. View

Zhang J, Li Y, Zhang C, Dai D . Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer. Cancer Cell Int. 2017; 17:28. PMC: 5314703. DOI: 10.1186/s12935-017-0387-9. View

Li X, Lin R, Li J . Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci. 2011; 56(10):2849-56. DOI: 10.1007/s10620-011-1711-1. View

Li C, Lu S, Shi Y . MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2. Oncol Rep. 2017; 37(3):1747-1755. DOI: 10.3892/or.2017.5370. View

Li D, Masiero M, Banham A, Harris A . The notch ligand JAGGED1 as a target for anti-tumor therapy. Front Oncol. 2014; 4:254. PMC: 4174884. DOI: 10.3389/fonc.2014.00254. View

Lai Y, Jiang Z, Zhou J, Osemota E, Liu Y . AP endonuclease 1 prevents the extension of a T/G mismatch by DNA polymerase β to prevent mutations in CpGs during base excision repair. DNA Repair (Amst). 2016; 43:89-97. PMC: 4955847. DOI: 10.1016/j.dnarep.2016.03.006. View

10.

Pronina I, Loginov V, Burdennyy A, Fridman M, Senchenko V, Kazubskaya T . DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Gene. 2016; 604:1-8. DOI: 10.1016/j.gene.2016.12.018. View

11.

Zhang C, Cao Y, Fu J, Yun J, Zhang M . miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33. Mol Oncol. 2016; 10(10):1532-1541. PMC: 5423132. DOI: 10.1016/j.molonc.2016.09.001. View

12.

Chen P, Xu W, Luo Y, Zhang Y, He Y, Yang S . MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK. Onco Targets Ther. 2017; 10:1423-1431. PMC: 5348068. DOI: 10.2147/OTT.S118366. View

13.

Geng Y, Lu X, Wu X, Xue L, Wang X, Xu J . MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7. Oncol Rep. 2016; 35(4):2441-50. DOI: 10.3892/or.2016.4572. View

14.

Ramalho-Carvalho J, Martins J, Cekaite L, Sveen A, Torres-Ferreira J, Graca I . Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Cancer Lett. 2016; 385:150-159. DOI: 10.1016/j.canlet.2016.10.028. View

15.

Fujiwara N, Inoue J, Kawano T, Tanimoto K, Kozaki K, Inazawa J . miR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity. Cancer Res. 2015; 75(18):3890-901. DOI: 10.1158/0008-5472.CAN-15-0257. View

16.

Zhang J, Fu J, Pan Y, Zhang X, Shen L . Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1. Onco Targets Ther. 2016; 9:7297-7307. PMC: 5138046. DOI: 10.2147/OTT.S111291. View

17.

Jou E, Rajdev L . Current and emerging therapies in unresectable and recurrent gastric cancer. World J Gastroenterol. 2016; 22(20):4812-23. PMC: 4873874. DOI: 10.3748/wjg.v22.i20.4812. View

18.

Ostling P, Leivonen S, Aakula A, Kohonen P, Makela R, Hagman Z . Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Res. 2011; 71(5):1956-67. DOI: 10.1158/0008-5472.CAN-10-2421. View

19.

Cui X, Wang S, Cai H, Lin Y, Zheng X, Zhang B . Overexpression of microRNA-634 suppresses survival and matrix synthesis of human osteoarthritis chondrocytes by targeting PIK3R1. Sci Rep. 2016; 6:23117. PMC: 4789801. DOI: 10.1038/srep23117. View

20.

Torre L, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87-108. DOI: 10.3322/caac.21262. View